Muscle cell therapy to treat muscular dystrophy and other degenerative diseases could be a more realistic possibility now that scientists have found a way to isolate muscle cells from human embryonic tissue.
You are here
Coverage of the latest news and updates from the field of stem cells.
The New York Stem Cell Foundation (NYSCF) Research Institute and PersonalGenomes.org have announced a partnership to identify genetic and environmental contributions to trait and disease development.
A team of researchers led by scientists at the Salk Institute for Biological Studies has developed a novel platform to study kidney diseases, opening new avenues for the future application of regenerative medicine strategies to help restore kidney function.
Researchers at MIT and Brigham and Women’s Hospital have shown that they can grow unlimited quantities of intestinal stem cells, then stimulate them to develop into nearly pure populations of different types of mature intestinal cells.
Scientists from the New York Stem Cell Foundation (NYSCF) Research Institute and Columbia University Medical Center (CUMC), both in New York City, have used stem cells created from the skin of patients with a rare form of diabetes to elucidate an important biochemical pathway for beta-cell failur
Scientists have been working for years to use the ability of stem cells to make multiple kinds of specialized cells and repair injuries throughout the body. But causing specialized adult cells to revert to stem cells and work on repairs has been challenging.
Using the technique, scientists were able to grow a pure, self-renewing population of stem cells specific to the human foregut, which is the upper section of the human digestive system. These cells could then be developed further to produce liver or pancreatic cells.
"We are excited to begin the next phase of this neural stem cell trial, further evaluating safety precautions while increasing both the number of injections and cells transplanted in ALS patients," says Jonathan Glass, M.D., director of the Emory ALS Center and principal investigator of the Emory
“If you think of a cell as a drug factory, what we’re doing is targeting cell-based drug factories to damaged or diseased tissues where the cells can produce drugs at high enough levels to have a therapeutic effect,” said Jeffrey Karp, Ph.D.
The research, by scientists at The Institute of Cancer Research (ICR), London, provides the latest evidence that despite having identical DNA, sister stem cells can display considerable differences in their molecular characteristics.